A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

NCT04699604 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Allergic Asthma

Interventions

DRUG: Levocetirizine Dihydrochloride
DRUG: Placebo

Sponsor

Bridgette Jones

Collaborators

[object Object]